Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation

被引:42
作者
Amaar, YG
Baylink, DJ
Mohan, S
机构
[1] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA
[2] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA
[4] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA
关键词
protein-protein interaction; yeast two-hybrid screen; small interfering RNA; extracellular signalregulated; kinase-1/2; phosphorylation; insulin-like growth factor-independent mechanism;
D O I
10.1359/JBMR.050311
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Introduction: It has been predicted that the intrinsic growth factor action of insulin-like growth factor binding protein (IGFBP)-5 involves either the binding of IGFBP-5 to a putative receptor to induce downstream signaling pathways and/or intracellular translocation of IGFBP-5 to bind to potential signaling molecules involved in osteoblast cell regulation. This study reports the characterization of isoform. C of the Ras association family 1 (RASSF1C) gene as an interacting partner of IGFBP-5. Materials and Methods: IGFBP-5 was used as bait in a yeast two-hybrid screen of a human osteosarcoma cDNA library. Expression levels of RASSF1C were measured by RT-PCR and/or Northern blot. IGFBP-5 effects on ERK phosphorylation were evaluated by immunoblot analysis. The effect of RASSF1C siRNA on cell proliferation was measured by the AlamarBlue assay. Results: One of the clones that interacted strongly with the bait under high stringency conditions corresponded to RASSF1C. The interaction between RASSF1C and IGFBP-5 was confirmed by in vitro coimmunoprecipitation studies. Northern blot and RT-PCR analysis showed that RASSF1C was expressed in a variety of osteoblast cell types that produce IGFBP-5. Addition of synthetic RASSF1C-specific small interfering (si) RNA duplex or use of a RASSF1C-specific si-hairpin plasmid caused a decrease in cell number and abolished IGFBP-5-induced extracellular signal-regulated kinase (ERK)-1/2 phosphorylation but had no effect on IGFBP-5-induced increases in alkaline phosphatase (ALP) activity. Conclusions: We have shown a novel interaction between IGFBP-5 and RASSF1C. Our findings that silencing of RASSF1C results in the reduction of osteoblast cell proliferation and that IGFBP-5 treatment increases phosphorylation of ERK-1/2 raise the possibility that RASSF1C, a Ras effector, could, in part, contribute to mediating the effects of IGFBP-5 on ERK phosphorylation and, consequently, cell proliferation.
引用
收藏
页码:1430 / 1439
页数:10
相关论文
共 42 条
[1]
Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2) [J].
Amaar, YG ;
Thompson, GR ;
Linkhart, TA ;
Chen, ST ;
Baylink, DJ ;
Mohan, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12053-12060
[2]
CARBOXY-TRUNCATED INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5 STIMULATES MITOGENESIS IN OSTEOBLAST-LIKE CELLS [J].
ANDRESS, DL ;
LOOP, SM ;
ZAPF, J ;
KIEFER, MC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (01) :25-30
[3]
Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor [J].
Andress, DL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (04) :E744-E750
[4]
Critical contribution of linker proteins to Raf kinase activation [J].
Anselmo, AN ;
Bumeister, R ;
Thomas, JM ;
White, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :5940-5943
[5]
The complex of recombinant human insulin like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration [J].
Bauss, F ;
Lang, K ;
Dony, C ;
Kling, L .
GROWTH HORMONE & IGF RESEARCH, 2001, 11 (01) :1-9
[6]
Ras pathway signaling on endomembranes [J].
Bivona, TG ;
Philips, MR .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :136-142
[7]
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression [J].
Burbee, DG ;
Forgacs, E ;
Zöchbauer-Müller, S ;
Shivakumar, L ;
Fong, K ;
Gao, BN ;
Randle, D ;
Kondo, M ;
Virmani, A ;
Bader, S ;
Sekido, Y ;
Latif, F ;
Milchgrub, S ;
Toyooka, S ;
Gazdar, AF ;
Lerman, MI ;
Zabarovsky, E ;
White, M ;
Minna, JD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :691-699
[8]
Ras signalling on the endoplasmic reticulum and the Golgi [J].
Chiu, VK ;
Bivona, T ;
Hach, A ;
Sajous, JB ;
Silletti, J ;
Wiener, H ;
Johnson, RL ;
Cox, AD ;
Philips, MR .
NATURE CELL BIOLOGY, 2002, 4 (05) :343-350
[9]
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function [J].
Cobb, LJ ;
Salih, DAM ;
Gonzalez, I ;
Tripathi, G ;
Carter, EJ ;
Lovett, F ;
Holding, C ;
Pell, JM .
JOURNAL OF CELL SCIENCE, 2004, 117 (09) :1737-1746
[10]
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J].
Dammann, R ;
Li, C ;
Yoon, JH ;
Chin, PL ;
Bates, S ;
Pfeifer, GP .
NATURE GENETICS, 2000, 25 (03) :315-319